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ABSTRACT: The magainins, peptide antibiotics secreted by the frog Xenopus laevis, have previously been 
shown to permeabilize phospholipid vesicles. To elucidate the mechanism of permeabilization, we have 
conducted detailed kinetic studies of magainin 2 amide (mgn2a)hduced release of 6-carboxyfluorescein 
from vesicles of phosphatidylserine. The results show that dye release occurs in (at least) two stages-an 
initial rapid phase, with t l p  = 3 s, followed by a much slower phase that approaches zero leakage rate before 
all the dye is released. Light-scattering studies showed that mgn2a does not cause gross changes in vesicle 
structure. The peptide was found to rapidly equilibrate betweenvesicles; this was demonstrated by determining 
a binding isotherm for the peptidelipid interaction, and by showing that addition of unloaded vesicles 
rapidly quenches peptide-induced leakage from loaded vesicles. Transient dye release in the presence of 
an equilibrating peptide can be explained in two ways: (1) the peptide exists only transiently in an active 
form; (2) the vesicles are only transiently leaky. Preincubation of mgn2a at  assay concentrations in buffer 
alone or with unloaded vesicles did not inactivate the peptide. Therefore, rapid leakage is probably due 
to transient destabilization of the vesicle upon addition of mgn2a. 
The magainins, a class of antimicrobial peptides secreted 
fromtheskinof thefrogxenopus laevis (Zasloff, 1987; Zasloff 
et al., 1988), are thought to kill cells by permeabilizing the 
plasma membrane. A total of 23 residues in length and bearing 
a positive charge of +3 to +5 at physiological pH, these peptides 
could potentially form amphipathic helical structures that 
are able to disrupt lipid bilayers or form oligomeric trans- 
membrane channels [see Williams et al. (1990) and references 
cited therein]. 
Evidence that magainins can act directly on lipid bilayers 
comes from studies with planar bilayers and liposomes. 
Duclohier et al. (1989) found that magainin 1 forms anion- 
selective channels in planar lipid bilayers under conditions of 
high salt and high trans-negative potential. Several conduc- 
tance states were identified, the lowest being 80 pS. The dose 
response curves suggested that the magainin channel consists 
of three to six monomers. 
When magainin 2 amide (mgn2a)l or its analogs were added 
to respiring cytochrome oxidase-containing liposomes (which 
have an inside-negative membrane potential), Juretic et al. 
(1 989) found that the peptides uncouple respiration and cause 
a stable (rather than transient) decrease in the steady-state 
membrane potential. The sigmoidal dose response curve was 
attributed to magainin monomers interacting cooperatively 
in the membrane to form an active aggregate of four to five 
subunits. 
These two studies suggest that the mechanism of magainin 
action is similar to that proposed for other voltage-dependent 
pore-formers, such as alamecithin [reviewed by Stein (1 986)]. 
According to the model, monomers or aggregates of the peptide 
initially bind to the bilayer interface (through a combination 
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Abbreviations: mgn2a, magainin 2 amide; PS, phosphatidylserine; 
PE, phosphatidylethanolamine; PC, phosphatidylcholine; SUV, small 
unilamellar vesicle; LUV, large unilamellar vesicle; CF, 6-carboxyflu- 
orescein; Pipes, piperazine-N,N’-bis(2-ethanesulfonic acid). 
of electrostatic and hydrophobic interactions) as an inactive 
amphipathic a-helix. The inactive form is then driven into 
the bilayer by the membrane potential, whereupon the peptide 
forms an active transmembrane pore. Changes in aggregation 
state can occur before, during, or after voltage-induced 
transmembranal insertion. 
There is, however, evidence to show that magainin effectively 
permeabilizes liposomes in the absence of a membrane 
potential: When magainin 1 was added to sonicated phos- 
phatidylserine (PS) vesicles, Matsuzaki et al. (1989a) found 
that entrapped calcein was rapidly released, on a time scale 
of seconds to minutes. By measurement of the initial rate of 
leakage as a function of total peptide and total lipid 
concentration, an equilibrium binding isotherm for the peptide- 
lipid interaction was also determined. The resulting curve, 
which fit well to the Langmuir equation, suggested to 
Matsuzaki et al. that extensive aggregation of peptide on the 
vesicle does not occur. From this, they concluded that 
magainin 1 probably does not form oligomeric channels in the 
bilayer, and therefore functions instead as a bilayer desta- 
bilizer. An important caveat, which they noted, is that their 
binding data are not sensitive enough to rule out the possibility 
that a small fraction of the peptide forms oligomeric channels. 
In our opinion, binding isotherms are exceedingly difficult to 
interpret because steric effects and changes in membrane 
surface potential lead to large activity coefficient effects that 
are hard to predict quantitatively (Schwarz et al., 1986). 
To help clarify the mechanism of magainin’s lytic action, 
we have studied in detail the kinetics of mgn2a-induced release 
of 6-carboxyfluorescein (CF) from phosphatidylserine lipo- 
somes in the absence of a membrane potential. Our results 
show that the fast release of dye is a transient effect. After 
experimentally eliminating several explanations, we conclude 
that fast release results from transient destabilization of the 
bilayer upon initial interaction with the peptide. A unifying 
mechanism for magainin action is proposed. 
EXPERIMENTAL PROCEDURES 
Materials. Phosphatidylserine (bovine brain) was pur- 
chased from Avanti Polar Lipids; Triton X-100, especially 
This article not subject to U.S. Copyright. Published 1992 by the American Chemical Society 
Permeabilization of Liposomes by Magainin 2 Amide 
purified for membrane research, was from Boehringer Man- 
nheim. Carboxyfluorescein from Eastman (>99%) was used 
for most of these studies, without further purification; 
chromatographically pure CF (Molecular Probes) was also 
used in selected experiments, and gave results indistinguishable 
from those obtained with Eastman CF. Magainin 2 amide 
was a generous gift from Dr. Hao-Chia Chen. 
Buffers. Buffers used in SUV studies were as follows: buffer 
A, 10 mM Pipes, 150 mM NaCl, 1 mM EDTA, and 100 mM 
sucrose, pH 7.0; buffer B, 10 mM Pipes, 150 mM NaC1,’and 
1 mM EDTA, pH 7.0; dye solution, 100 mM CF, 10 mM 
Pipes, 150 mM NaCl, and 1 mM EDTA, pH 7.0. 
Preparation of Small Unilamellar Vesicles ( S W s ) .  Be- 
cause the phase transition of the bovine brain PS is 8 “C, 
SUVs and LUVs had to be prepared and stored above this 
temperature; for convenience, all procedures were carried out 
at or near room temperature. 
Approximately 20 mg of PS in 2 mL of solvent was dried 
to a film in a 25-mL flask by rotary evaporation, redissolved 
in 5 mL of benzene, and lyophilized overnight under high 
vacuum. The lyophilized lipid was then suspended in 2 mL 
of dye solution by vortex mixing, transferred to a polycarbonate 
tube, and sonicated (under argon) at 25-30 OC to constant 
clarity in a cup horn using a Heat Systems ultrasonic sonicator 
(W-375). Unentrapped CF was removed from the solution 
by passing the sonicate through an Econo-Pac lODG column 
(10 mL) using buffer A as the eluting buffer. 
To obtain a homogeneous population of SUVs, larger 
particles were removed by sedimentation in an angle rotor 
(Ti50, Beckman ultracentrifuge), as described by Barenholz 
et al. (1977). Centrifugation at 45K rpm for 15 min was 
sufficient to produce a population of CF-loaded lipsomes that 
elutes as a homogeneous population of SUVs from a Sepharose 
2B-CL column: A single, well-included peak was obtained, 
with a constant ratio of CF/phosphate across the elution 
profile. This result also shows that the vesicles are relatively 
stable, since vesicle breakdown or fusion usually produces a 
heterogeneous mixture of particles. Lipid phosphate was 
determined by the method of Bartlett (1959). 
Preparation of Large Unilamellar Vesicles ( L W s ) .  CF- 
loaded PS LUVs were prepared by the reverse-phase ether 
evaporation method (Diizgiines et al., 1983), using 100 mM 
CF, 10 mM Pipes, 10 mM NaC1, and 1 mM EDTA, pH 7.0 
(296 mOsM), as the aqueous phase. The initially formed 
vesicles were extruded successively through Nucleopore filters 
of 0.4, 0.2, 0.1, and 0.08 pm. To remove unentrapped CF 
and contaminating SUVs, the vesicles were passed through 
an Econo-Pac lODG column (10 mL) and then a Sepharose- 
2BCL column (1.6 X 60 cm), using 10 mM Pipes, 150 mM 
NaC1, and 1 mM EDTA, pH 7.0 (295 mOsM), as the eluting 
buffer. 
CF Release Assay. Release of CF from the vesicles at 25 
“C was determined fluorometrically by monitoring the 
decrease in self-quenching (excitation 490 nm, emission 520 
nm; Aminco SPF-5OOC spectrofluorometer) as the dye is 
released from the vesicles (Weinstein et al., 1984). 
Kinetic experiments were usually initiated by injecting 5-20 
pL of peptide stock solution (0.37 mM mgn2a in buffer B) 
into a magnetically stirred, equilibrated cuvette containing 2 
mL of 25-30 pM PS in buffer A. The mixing time was about 
1 s. At the end of each run, the total releasable fluorescence 
wasdeterminedby theadditionof 20pLof lO%TritonX-lOO. 
Progress of the reaction is reported as the percentage of CF 
quenched, %Q, which is calculated from the formula [ 1 - (F, 
- F0)/(Fm - Fo)] 100, where F, is the fluorescence at time t ,  
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FO is the base-line fluorescence of the vesicles, and F, is the 
fluorescence after Triton X-100 addition. As will be shown 
under Results, mgn2a induces the release of dye by an all- 
or-none mechanism. Consequently, %Q equals the percentage 
of total dye remaining in the vesicles. 
The kinetics of dye release from SUVs were not significantly 
affected by the osmolarity of the bathing solution. This was 
determined by varying the osmolarity of buffer B from 33 1 
to 804 mOsM with sucrose. The osmolarity of the dye solution 
was 600. 
Isoosmotic conditions were used to measure the release of 
dye from LUVs, using the dye solution and external buffer 
described above in the section on LUV preparation. 
Mode of Dye Release. Dye may be released from a 
population of vesicles by an “all-or-none” or a ”graded” process; 
the all-or-none mode of release produces a mixture of fully 
loaded and completely unloaded vesicles whereas the graded 
mode produces a population of vesicles that are all partially 
unloaded to the same extent. These two modes of release can 
be distinguished by determining the percentage of fluorescence 
quenching remaining in the intravesicular medium, %Qtr, after 
a substantial fraction of dye has been released from thevesicle 
sample (Weinstein et al., 1984). 
To determine the mode of release, mgn2a was added to 
SUVs (25-30 pM PS) containing either 30 mM or 100 mM 
entrapped CF. After 100 or 500 s, an aliquot of unloaded 
vesicles (6 pL of 85 mM PS) was added to quench the mgn2a- 
induced release of dyevia intervesicular equlibration of peptide. 
To separate the vesicles from released dye, 1-mL aliquots of 
the mgn2a/SUV mixture were rapidly passed over 5-mL 
Sephadex G25 columns by centrifugation at a maximum speed 
for 15 s (at room temperature) in a clinical centrifuge. Vesicle 
fractions of 0.5 mL were then analyzed in the absence and 
presence of Triton X-100 to determine the percentage of 
fluorescence quenching. From these results, the intravesicular 
concentration of CF could be determined from a standard 
quench curve, which was obtained by measuring the fluo- 
rescence quenching of vesicle samples prepared in solutions 
ranging from 1 to 100 mM CF. 
Light Scattering. To determine whether mgn2a induces 
gross structural changes of the vesicles by fusion, aggregation, 
or solubilization, changes in the 90” light scattering of vesicle 
solutions were monitored with the spectrofluorometer. An 
incident wavelength of 400 nm was used, with band-pass slit 
settings at 4 nm. 
Even if no gross structural changes take place, a modest 
increase in light scattering is expected because bound peptide 
increases the mass of the vesicle and perhaps the refractive 
index increment as well. The predicted magnitude of these 
increases was calculated as described previously by Roseman 
et al. (1977) in a study of cytochrome bs-vesicle interactions. 
Briefly, the Rayleigh equation shows that the relative increase 
in light scattering of an SUV-peptide complex compared to 
SUV alone depends on three ratios: the relative molecular 
weights, the relative concentrations in grams per milliliter, 
and the relative refractive index increments. From our 
experimentally determined mgn2a-lipid binding isotherm, the 
relative molecular weights and relative concentrations of 
particles could readily be calculated. The refractive index 
increments, which were not measured, had to be estimated 
fromreported values for pure lipid (0.1478 mL/g) and protein 
(range: 0.1 5-0.2 mL/g); for thesecalculations, it was assumed 
that the refractive index increment of a complex is a simple 
weighted average of the refractive index increments of the 
pure components. 
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FIGURE 1: mgn2a-indud release of CF from PS SUVs. 5-20 pL 
of 0.37 mM mgn2a (in buffer B) was injected into a stirred cuvette 
containing a 2-mL solution of CF-loaded SUVs (30 pM in PS) in 
buffer A, and the increase in fluorescence intensity (excitation 490, 
emission 520) was monitored. See Experimental Procedures for 
further experimental details. The final concentrations of mgn2a in 
the six reaction mixtures A-F were, respectively, 0,1.30, 1.852.22, 
2.78, and 3.70 pM. 
100 I I / 1 
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FIGURE 2: Leakage rate as a function of total peptide concentration 
at four concentrations of SUVs. The concentrations of PS were 25 
(diamonds), 50 (squares), 75 (circles), and 100 rM (triangles). The 
leakage rate is defined as the percentage of dye released in the first 
minute. 
RESULTS 
Effect of mgn2a on the Permeability of PSSUVs. As shown 
in Figure 1, addition of mgn2a to PS SUVs causes the release 
of CF, but the kinetics are not simple first order; dye is released 
in a rapid initial phase, lasting about 100 s, followed by a 
much slower phase. 
To narrow down the number of plausible explanations for 
these kinetics, it is necessary to know (1) whether the peptide 
readily equilibrates between vesicles, (2) the number of 
peptides bound per vesicle, and (3) whether the peptide induces 
gross structural changes in the vesicles. 
Determination of a Binding Isotherm for the mgn2a-PS 
Interaction. A binding isotherm for the mgn2a-PS SUV 
interaction was obtained by the “indirect method”, which has 
been used to determine the affinity of permeabilizing agents 
for cells or liposomes (Thron, 1964; Matsuzaki et al., 1988, 
1989b). The first step, as shown in Figure 2, is to measure 
the fractional leakage rate (%Q/s)  as a function of peptide 
concentration at several fixed concentrations of lipid. Next, 
a set of lines parallel to the x axis is drawn through the four 
dose response curves, giving for each line four pairs of [PO],- 
0.00 v I I I I I 
0.00 0.20 0.40 0.60 0.80 1 .@I 
FIGURE 3: Binding isotherm for the interaction of mgn2a with CF- 
loaded PS SUVs. 
[Plf (PM) 
0.00 0.03 0.06 0.m 0.12 0.15 
r 
FIGURE 4: Dose response curve relating leakage rate to the ratio of 
moles of peptide bound per mole of lipid. 
[L] values that produce an equivalent fractional leakage rate. 
[PO] and [L], the total molar concentrations of peptide and 
lipid, respectively, are functionally related to the concentrations 
of bound and free peptide by the conservation equation: 
[Pol = [Pfl +r [Ll  
where [Pf] is the concentration of free peptide and r is the 
molar solution concentration ratio of bound peptide per lipid. 
Since all pairs of [PO], [L] values that produce a given fractional 
leakage rate must also produce the same value of r, plots of 
[PO] versus [L] at constant fractional leakage rates are linear, 
withslopesofrandinterceptsof [Pf]. Thesetofr,[Pf] obtained 
from these plots constitutes the binding isotherm, shown in 
Figure 3. From the slope of a line drawn through the 
experimental points, an apparent binding constant of 1.12 X 
lo5 M-’ was obtained. 
A dose response curve relating the fractional leakage rate 
to the amount of peptide actually bound is shown in Figure 
4. The experimental points lie on a straight line that 
extrapolates to an intercept of r = 0.03, which is the “critical 
number” of peptide monomers that must be bound per mole 
of lipid to induce leakage. In our kinetic experiments, rvaried 
from 0.06 to 0.14, which corresponds to 60-250 peptide 
molecules bound per SUV. Because this ratio is so high, no 
vesicle was devoid of peptide during a kinetic run. 
Although binding isotherms are frequently used in attempts 
to deduce the state of peptide aggregation on the vesicle surface, 
definitive interpretations are not always possible because it is 
difficult to take into account steric effects and changes in 
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Table I: mgn2a-Induced Increases in Light Scattering of SUVs' 
predicted changes in iJiv 
[mgn2a] with no fusion with fusion 
(rMlb or aggregationC or aggregationd observed 
0.93 1.17-1.23 >2.34 1 .31  
1.30 1.25-1.34 >2.50 1.23 
1.85 1.34-1.47 >2.68 1.54 
2.22 1.44-1.61 >2.88 1.91 
2.78 1.56-1.78 >3.12 1.92 
3.70 1.77-2.09 >3.54 2.38 
The relative increase in 90° light scattering ( ic / iv)  was determined 
with a spectrofluorometer as described under Experimental Procedures. 
5-20 pL of 0.37 mM mgn2a was added to SUVs ([PSI = 30 pM) in 
buffer A, vesicles contained 100 mM entrapped CF. An immediate 
increase in light scattering was observed, which showed no further change 
over 500 s. Range of values reflects uncertainty in the refractive index 
increment (see Experimental Procedures). Lower limit estimate, as- 
suming all peptidevesicle complexes double in mass. The values were 
obtained by multiplying the smaller number in the previous column by 
a factor of 2. 
vesicle surface potential upon peptide binding (Schwarz et 
al., 1986). We shall avoid any attempt to do so here. 
For our purposes, the most important result is that the 
mgn2a-vesicle interaction appears to be reversible. This was 
substantiated by the following experiment. To a mixture of 
3.7 pM mgn2a and loaded SUVs (30 pM PS) was added 5 
pL of unloaded vesicles (11.5 mM PS) at 10, 30, and 60 s 
after the peptide was injected. In each case, leakage stopped 
almost instantly after injection of unloaded vesicles. The most 
reasonable conclusion is that the level of mgn2a bound to the 
loaded vesicles was reduced by peptide equilibrating between 
loaded and unloaded vesicles. 
Light-Scattering Studies. To determine whether mgn2a 
causes gross structural changes in the SUVs, the 90° light 
scattering of a vesicle solution was measured before and after 
addition of peptide. As shown in Table I, peptide causes a 
dose-dependent increase in the relative light scattering, up to 
a value of 2.38. This increase can be attributed mainly to the 
increase in mass and perhaps refractive index increment of 
the particles contributed by the peptide, as shown by the 
theoretical calculations in column 2. 
Column 3 shows the theoretical lower limit for a light- 
scattering increase that would occur if all the initial SUVs 
(with bound peptide) uniformly increased in size by undergoing 
a single fusion event. Clearly, these values are substantially 
higher than the ones observed. Moreover, this lower limit 
prediction is highly conservative, if not unrealistic, since it 
has never been observed (to our knowledge) that bilayer- 
destabilizing peptides or proteins cause such a controlled, 
limited aggregation or fusion of vesicles; in all reported studies 
of protein- or peptide-induced fusion [reviewed in Maezawa 
et al. ( 1989)], the protein or peptide causes massive aggregation 
of vesicles, or the formation of a heterogeneous dispersion of 
vesicles that results from multiple fusions. It should also be 
noted that the kinetics of aggregation or fusion are usually 
sufficiently slow (with half-times of a few seconds to minutes) 
that time-dependent changes in light scattering are observed 
upon addition of peptide or protein. In our experiments, 
however, the changes in light scattering appear to be 
instantaneous and do not increase with time. 
From our results, calculations, and the reported effect of 
known fusogens on lipid vesicles, we conclude that mgn2a 
does not induce a significant fusion or aggregation of PS SUVs. 
KineticStudiesof the Biphasic Releaseof CF. Since mgn2a 
(including any lytic form) rapidly equilibrates between vesicles, 
a simple model whereby the peptide reversibly forms channels 
~ 
Table 11: Mode of mgn2a-Induced Dye Release from SUVs' 
predicted %Q 
[mgn2a] duration of %CF all-or-none graded 
(pM) run (s) release release release observed 
0 100 0 80 
1.85 13 80 78 82 
2.22 17 80 77 80 
2.78 28 80 74 80 
3.70 64 80 56 79 
0 500 0 80 
1.85 18 80 77 80 
2.22 30 80 73 80 
2.78 50 80 67 79 
3.70 82 80 36 76 
SUVs (25-30 pM in PS) started with 30 mM entrapped CF. Details 
of how both the predicted and observed values were obtained are given 
under Experimental Procedures. The error in %Q is &1.5%. 
cannot explain why only a fraction of the dye is released in 
the fast phase. One possibility is that magainin is inactivated 
during the initial 100 s by interaction with the vesicles. This 
was tested by preincubating mgn2a (1.85-3.7 pM) with 
unloaded vesicles (5 r M  in PS) for 100 s before addition of 
loaded vesicles (final [PSI = 25 pM). Fast release was still 
observed (data not shown), of a magnitude predicted for this 
ratio of loaded to unloaded vesicles. Evidently, the peptide 
remains active. 
Biphasic kinetics could also arise from putative highly lytic 
peptide aggregates that exist in the concentrated stock solution, 
but which disaggregate in the assay mixture. This was tested 
by preincubating mgn2a for up to 24 h in the cuvette at assay 
concentrations before adding vesicles. The release kinetics 
were essentially the same, making this explanation unlikely. 
[It should be noted that in these experiments the cuvette 
was rinsed with mgn2a solution before adding the preincu- 
bation solution. Without the prerinse, the activity of mgn2a 
decreases slowly if the solution is allowed to stand and decreases 
rapidly if the solution is continuously stirred. The simplest 
explanation is that in the absence of lipid, the cationic peptide 
adsorbs to the glass walls of the cuvette, and that stirring 
accelerates this process by eliminating diffusion as a rate- 
limiting step. Tosteson et al. (1985) have previously reported 
that melittin, a positively charged peptide, also binds to glass.] 
If the intrinsic activity of the peptide remains constant, 
then it must be the vesicles that undergo transient changes. 
Some insight into the nature of these events can be obtained 
from determining the mode of dye release. 
As discussed earlier, dye may be released in an all-or-none 
or a graded fashion. These mechanisms are distinguished by 
measuring the percent quenching remaining in the vesicles, %etr, after a significant fraction of total dye has been released; 
if release is all-or-none, %Qtr stays constant, whereas if release 
is graded, %Qtr decreases by an amount that can be determined 
from a standard quench curve. 
After addition of mgn2a to the vesicles, the residual 
quenching of entrapped dye was determined near the end of 
the fast phase (100 s) and at a later time point (500 s) in an 
attempt to discern the mode of release for each phase of the 
reaction. The results are shown in Table 11. By comparing 
theexperimental results with those predicted for the twomodes 
of release, it is clear that release is all-or-none during the first 
100 s. 
A similar comparison of %Qtr at 500 s appears to indicate 
that all-or-none release continues through the slow phase as 
well. However, before drawing such a conclusion, it must be 
shown that in theory, a purely all-or-none release would 
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FIGURE 5: Effect of adding successive additions of mgn2a to loaded 
SUVs. mgn2a was added to SUVs of 29 pM PS. Curve A: 1.1 1- 
nmol additions were made at f = 0, 109, and 234 s. Curve B: 1.85- 
nmol additions were made at t = 0,109, and 204 s. Curve C: 2.59- 
nmol additions were made at t = 0,99, and 194 s. Curve D: 3.70- 
nmol additions were made at t = 0 and 11 5 s. Arrows indicate the 
times of addition. 
produce a significantly different %Qt, than a process involving 
a change fromall-or-none to graded. Using a standard quench 
curve, a calculation showed that it is possible to discern the 
mode of release during the slow phase, but only in the runs 
where the two highest levels of mgn2a were used, i.e., 15 and 
20 pg. In those cases, a sequential bimodal release (all-or- 
none followed by graded) should have produced final %Qtr 
values of 74 and 64%, respectively; these differ sufficiently 
from the starting %Qtr, so that a bimodal release could have 
been detected if it had occurred. From the experimentally 
determined values of 79 and 76%, we conclude that release 
over the 100-500-s interval is primarily all-or-none. 
There are two ways that lysis of the vesicles could arise. 
Interaction with peptide could induce instability into the 
vesicles, which then relax to stable proteoliposomes accom- 
panied by lysis of a fraction of the vesicles. (Stability is defined 
here as the lowest free energy for vesicles of a given size.) 
Alternatively, the vesicles might start out in a metastable 
form before the peptide is added. If so, the peptide would 
function solely as a catalyst that facilitates relaxation of the 
unstable vesicles to a more stable structure, accompanied by 
lysis of a fraction of the vesicles. Preexisting metastability 
could result from the method of preparation, such as sonication. 
These alternatives can be distinguished by adding more 
magainin at the end of the fast phase. If the peptide induces 
instability, another fast phase should be observed, but if it 
acts catalytically, the vesicles should all be relaxed by the 
time of the second peptide addition; consequently, no additional 
fast-release phases should occur. 
As shown in Figure 5 ,  a new fast phase is induced with each 
addition of peptide, indicating that lysis arises from peptide- 
induced vesicle instability rather than preexisting vesicle 
instability. 
In further support of this conclusion, we find that mgn2a 
induces biphasic release of dye from LUVs (data not shown), 
the only difference being that approximately half as much 
mgn2a is required to achieve the same %Q as with SUVs. 
Since LUVs are not produced by sonication, and are too large 
to be affected by curvature-induced strain, whatever might 
cause the putative metastability of SUVs is unlikely to be 
present in LUVs. 
Kinetics of Detergent-Induced Dye Release. As shown 
earlier, mgn2a does not begin to induce measurable CF release 
P + v e  pv*- > p V ’ = p + V ’  
PVp slow leak 
fast leak 
until the level of bound peptide becomes quite high, at r = 
0.03. To compare the intrinsic permeabilizing activity of 
mgn2a with that of detergents, the effect of octyl glucoside 
and Triton X-100 on CF release from PS SUVs was 
determined. From the leakage kinetics and the published 
values of the bilayer/water partition coefficients for these 
detergents (Paternostre et al., 1988), dose response curves 
relating r to the fractional leakage rate can be obtained. Our 
results (not shown) are essentially the same as those reported 
by Lasch et al. (1990) in a study of the effect of these detergents 
on the release of CF from LUVs of egg PC: measurable 
leakage was not observed until the r values for Triton X-100 
and octyl glucoside reached about 0.07 and 0.175, respectively. 
[The leakage rate sharply increases at r = 0.42 (Triton X- 100) 
and r = 0.23 (octyl glucoside); these are the upward turning 
points of the sigmoidal dose response curves.] 
When compared on a weight basis (grams per mole of lipid), 
the r values at leakage onset for mgn2a, Triton X-100, and 
octyl glucoside are remarkably similar-81, 44, and 51, 
respectively. 
DISCUSSION 
The simplest model that is at least qualitatively consistent 
with all of our results is the bilayer destabilization mechanism, 
shown in Scheme I. 
In the first step, peptide reversibly binds to the vesicles to 
form a destabilized vesicle, PV*. Destabilization is suggested 
to arise from a packing imbalance created by the accumulation 
of peptide on or in the outer monolayer of the vesicle. PV* 
then undergoes a rapid, irreversible relaxation, perhaps by 
lipid translocation, to a more stable proteoliposome, PV’, which 
exists in equilibrium with free peptide. Although the scheme 
suggests that the stable vesicle V‘ is devoid of protein, V‘ 
represents a proteoliposome with an equilibrium level of peptide 
bound to the outer monolayer; the packing and distribution 
of lipid in this proteoliposome is a variable that is dictated by 
the amount of protein bound to the surface. At the end of the 
fast release phase, the only species present are PV’, P, and V’. 
During the lifetime of PV*, fluctuating pores (V,) form 
within the lipid bilayer. In the scheme, the conversion of PV* 
to PV, represents the rate of forming pores large enough to 
release CF. It is assumed that once a pore this large is formed, 
all the dye is released from that vesicle before the pore 
dissipates. Therefore, the rate-limiting step in the release of 
dye from PV* is the conversion of PV* to PV,; the arrow 
leading back from PV, to PV* represents the dissipation of 
a pore in an unloaded vesicle. 
This model accounts for the limited fast release of dye by 
an all-or-none mechanism in a system with a persistently active 
peptide that exchanges between vesicles. To account for the 
observation that further addition of peptide at the end of the 
fast phase induces another fast phase (Figure 5), we suggest 
that V’ must undergo further destabilization and relaxation 
to accommodate a higher level of peptide. 
For this minimal model, only one transiently destabilized 
form of the vesicle (PV*) is postulated. If relaxation occurs 
Permeabilization of Liposomes by Magainin 2 Amide 
Scheme I1 
k i  k 3  k5  * kn P + v =PV* -> PV -> PV**' -> ... P V ~  -> 
PVp* PV PVp'** PVnp' 
... PV' P + v' 
PVp' 
through a series of intermediates, the reaction scheme can be 
expanded according to the general form shown in Scheme I1 
where the rate constants with even-numbered subscripts 
represent the leak rate from each intermediate and k, is the 
final leak rate in the slow phase. If the free and bound peptides 
are in rapid equilibrium, the rate equation for this mechanism 
simplifies to a sum of first-order exponentials: 
F = A exp[-(k, + k2)t] + 
B exp[-(k, + k4)t] ...+ Z exp(-k2t) 
where Fis the percentage of the vesicle population that contains 
dye and is equal to %Q because the mode of release is all- 
or-none. The preexponential terms are complex expressions 
of rate constants. 
A nonlinear least-squares analysis (Bevington, 1969) of our 
%Q vs t curves indicates that at the highest levels of added 
mgn2a (where the signal/noise ratio is most favorable) the 
kinetics are closely fit by a triexponential, %Q = A exp(-kat) 
+ B exp(-kbt) + C exp(-k,t) + D, with the following values 
for the constants, in s-l: A = 41.6, k, = 0.192; B = 26.9, kb 
= 0.00756; C = 23.2, kc = 0.0011; D = 5.71. These results 
suggest that vesicle relaxation is a multistep process. 
The alternative to bilayer destabilization is that the peptide 
forms transient oligomeric channels in the bilayer, but the 
only reasonable explanation for the transient nature of such 
a putative channel is that it exists only in a transiently 
destabilized bilayer. If so, the function of the channel is 
superfluous since a destabilized bilayer itself is a breach of 
the permeability barrier. Therefore, explanations based upon 
peptide-lined pores are hard to rationalize. 
Since we favor a bilayer destabilization mechanism, it would 
be informative to compare the characteristics of mgn2a- 
induced leakage with the characteristics of detergent-induced 
leakage. In particular, we would like to know whether 
detergents ever induce biphasic release kinetics, cause leakage 
by an all-or-none mode of release, or have a specific activity 
comparable to that of mgn2a. 
Some detergents do show biphasic release kinetics: Schubert 
et al. (1 986) and Lasch et al. (1 990) have found that cholate 
and deoxycholate release only a fraction of entrapped solute 
(the extent of which depends on the amount of detergent added) 
even after prolonged times. Schubert et al. suggest that leakage 
is due to the formation of transient holes in the bilayer, which 
is essentially what we are proposing to account for mgn2a 
action. 
To our knowledge, all-or-none release has not been looked 
for in studies with liposomes. However, it has been shown 
that detergents can induce an all-or-none lysis of cells (Scharff, 
1960; Maas, 1969; Silhankova, 1959) and some detergents 
cause discrete conductance fluctuations in planar bilayers 
(Blumenthal & Klausner, 1982). 
The specific activities of mgn2a and detergents are com- 
parable. Leakage onset does not occur until the levels of bound 
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magainin (on a weight basis of grams per moleof phospholipid) 
equal or exceed the high critical values observed with 
detergents: for mgn2a, 8 1; Triton X- 100,44; octyl glucoside, 
5 1. Although it seems fortuitous that a cationic amphipathic 
peptide should have a comparable activity to two neutral 
detergents, it is interesting to note that cholate, with an 
amphipathic architecture and charge that is different from 
Triton X-100 and octyl glucoside, also shows a similar critical 
r value: the release of raffinose from egg PC LUVs does not 
occur until r equals about 0.15 (Schubert et al., 1986), which 
is 65 g of cholate/mol of phospholipid. 
As noted earlier, magainin forms channels in highly 
polarized (>lo0 mV) planar lipid bilayers composed mainly 
or exclusively of neutral phospholipids (Duclohier et al., 1989). 
In contrast, we have observed (unpublished observation) that 
addition of mgn2a to planar bilayers composed of PC/PE/PS 
under a trans-negative potential of <80 mV increases the 
macroscopic conductance without evidence of discrete con- 
ductance states. Also, although liposomes of the same lipid 
composition are readily permeabilized by mgn2a, when mgn2a 
was added to the planar bilayers in the presence of liposomes 
(to maintain the same protein:lipid ratio that induces rapid 
dye release from the liposomes), no significant change in 
membrane conductance was seen. 
From our results and those obtained by others, we can 
explain the action of magainin in a variety of model membrane 
systems by making three assumptions. First, an increase in 
the negative charge of the membrane increases the affinity of 
the bilayer for the cationic peptide, which promotes transient 
bilayer destabilization and leakage. Second, an increase in 
the negative surface charge of the membrane from anionic 
phospholipids inhibits voltage-induced channel formation by 
causing the peptide to remain bound in an electrically neutral 
(and therefore potential-insensitive) complex at the vesicle 
surface or interface. Third, planar bilayers are more resistant 
than liposomes to peptide-induced transient destabilization 
because planar bilayers can relieve the strain by transferring 
lipid into or out of the torous or by bending in either the cis 
or the trans direction. 
To summarize, mgn2a can permeabilize membranes via 
bilayer destabilization or by channels. Which mechanism 
predominates depends on the membrane system, composition, 
and degree of polarization. 
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